Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy.

Of note, glycoprotein acetyls A and B levels at first draw were significantly higher in patients who died during our study (survival ‘no’) and generally showed an increasing trend over time ( Supplementary Figure 6 ).

also in 63,971 other papers